The Guardian: Our fearless leader, Linden Hu, was interviewed by Nicola Davis for The Guardian in an article about how the diagnosis of Lyme disease in England is up more than 20% in a year. He spoke about why human Lyme prevention has lagged behind veterinary medicine, and where the field is headed. He highlighted that dogs have better Lyme prevention than people do, at the moment, why an earlier vaccine (LYMErix) was withdrawn from the market, how new vaccines are being designed and some of the current progress towards new Lyme vaccines and tools to prevent infection.

Portland Press Herald: Tufts Lyme Disease Initiative Co-Director, Robert Smith, spoke to Joe Lawlor for the Portland Press Herald about the PROSSECO study. PROSSECO began in 2025 and is starting its second enrollment season. The study enrolls patients when they are first diagnosed with Lyme disease, and observes their recovery over several time points during and treatment, studying why some people continue to have symptoms months or years after contracting the infection.

CBS 60 Minutes:  MIT professor Kevin Estvelt and Tufts Lyme researcher Sam Telford discuss a new approach to eradicating Lyme disease by making one of its reservoir hosts, the white footed mouse, resistant to infection with the Lyme bacteria. In 2013, Esvelt was the first to identify that CRISPR, a technology that allows scientists to modify DNA, could be used to change a species’ genetics in perpetuity. His discovery led to Mice Against Ticks, a project run out of Esvelt’s Sculpting Evolution lab at MIT. For the last nine years, he and researcher Joanna Buchthal have looked into whether they could add a gene for an antibody that prevents Lyme disease to a mouse embryo that has progressed into two cells. The lab’s technique involves injecting both cells to maximize the likelihood of getting the antibody into the DNA.  Dr. Telford is helping the team plan testing on Nantucket Island.

Boston Globe: With the tick-borne illness making its annual resurgence in the region, researchers from Tufts University School of Medicine say they have discovered a new way to identify the disease, looking at an antibody generated in response to the infection, that can help people receive more effective treatment.

There are real problem areas in the current tests that impact a lot of people,” said Peter Gwynne, lead author of the study and a molecular biology and microbiology researcher at Tufts University School of Medicine.

Dr. Robert Smith, co-director of the Tufts Lyme Disease Initiative, gives Grand Rounds and discusses the forces behind the rise in tick borne diseases and how we might stop them. Use the password d7xY$0$P to watch the video.

Dr. Lin and his colleagues have been awarded a five-year, $4 million National Institute of Health (NIH) Research Grant (R01)  to study how wild birds serve as hosts of the Lyme disease bacteria and birds’ immune responses to the pathogen. The research aims to develop more efficient prevention techniques to minimize the spread of Lyme disease from animals to humans.